Skip to main content
. Author manuscript; available in PMC: 2010 Dec 20.
Published in final edited form as: Cell Cycle. 2009 Feb 21;8(3):345–356. doi: 10.4161/cc.8.3.7494

Figure 3.

Figure 3

Components of pri-miRNA/SC35-containing nuclear foci. Cells transfected with pri-let-7 were subjected to IF using antibodies directed against (A) ASF/SF2, (B) PABII, (C) Pol II or (E) PM/Scl-100, followed by in situ hybridization to pri-let-7. In (D), cells were cotransfected with pri-let-7 and GFP-Pin1, and ISH to pri-let-7 was performed. Arrowheads in (B) (part b) indicate untransfected cells. Scale bars, 10 μm.